SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

EWTX

Edgewise Therapeutics, Inc.
NASDAQHealth Care

Latest close: 37.19 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 13, 2026Reported sale · Form 4Joanne M. Donovan, CMO · $126.7KOpen the filing ↗
  2. Aug 13, 2026Notice of sale · Form 144JOANNE DONOVAN · Officer · $127.2KOpen the filing ↗
  3. Aug 12, 2026Reported sale · Form 4KEVIN KOCH, President and CEO · $383.3KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record40019 flagged findings
Reported transactions (Form 4)80since Jan 21, 2026
Corporate events (8-K)18since Sep 14, 2022

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…based on prevailing market conditions and the timing of cash deployment. Liquidity and Capital Resources Sources of liquidity…”
    +1 more passage from the same document
    • “…preferred stock and public offerings of our common stock. From inception to our initial public offering, private placements provided…”
  • 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗
    “…ourselves. The issuance of additional equity securities may cause our stockholders to experience dilution. Future equity or debt…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 400)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 2, 26Form 4 ↗Insider transaction
  • Insider transaction · 5 Form 4/A filingsshow all 5hide
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · RA Capital Management, L.P. · 7.8% · event on Jun 30, 26 · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Paradigm BioCapital Advisors LP · 9.5% · event on Jun 30, 26 · amendment
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Baker Bros. Advisors LP · 3.4% · event on Jun 30, 26 · amendment
  • Aug 13, 26Form 144 ↗Notice of proposed sale
  • Aug 6, 268-K ↗Current report · Results
  • Aug 6, 2610-Q ↗Quarterly report
  • Aug 6, 26SCHEDULE 13G ↗Passive stake · FMR LLC · 5.1% · event on Jun 30, 26
  • Jul 17, 26Form 4 ↗Insider transaction
  • Jul 16, 268-K/A ↗Current report · Financial statements and exhibits · amendment
  • Jul 13, 268-K ↗Current report · Completed an acquisition or disposal
  • Jul 2, 26Form 4 ↗Insider transaction
  • Jul 1, 26Form 144 ↗Notice of proposed sale
  • Jul 1, 26Form 4 ↗Insider transaction

400 filings on record, the oldest from Jan 12, 21.

Listing the 25 most recent filings of the 400 on record.

8-Ks, explained

Stress2Structure9Governance7
  • Jul 13, 26StructureCompleted an acquisition or disposal+2 more in the same filing8-K 2.01 ↗
  • Jun 1, 26StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Nov 20, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Nov 10, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 2, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jan 22, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Aug 12, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 10, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • May 7, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 19, 24StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Jul 14, 23StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Jun 22, 23StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗

3 older filings not shown

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • ORBIMED ADVISORS LLC14.5%May 9, 25SCHEDULE 13D/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum.
  • Novo Holdings A/S4.9%Apr 23, 26SCHEDULE 13D/A ↗

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Paradigm BioCapital Advisors LP9.5%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • RA Capital Management, L.P.7.8%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • JANUS HENDERSON GROUP PLC5.5%Mar 31, 26SCHEDULE 13G ↗3 earlier filings
  • BlackRock, Inc.5.5%Jun 30, 25SCHEDULE 13G/A ↗
  • FMR LLC5.1%Jun 30, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
show 2 more holdershide
  • Perceptive Advisors LLC4.4%Jun 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Baker Bros. Advisors LP3.4%Jun 30, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Aug 13, JOANNE DONOVAN filed notice of intent to sell up to $127K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $127K on Aug 13, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

View notice (Form 144) ↗+1 more recent notices · 1 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 13, 26Sell$127KJoanne M. DonovanCMO↗
  • Aug 12, 26Sell$383KKEVIN KOCHPresident and CEO↗
  • Aug 12, 26Sell$361KKEVIN KOCHPresident and CEO↗
  • Aug 12, 26Sell$40KKEVIN KOCHPresident and CEO↗
  • Aug 12, 26Sell$107KJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Sell$3KJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Sell$4KJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Sell$106KJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Sell$124KJoanne M. DonovanCMO↗
  • Aug 12, 26Sell$121KJoanne M. DonovanCMO↗
  • Aug 12, 26Sell$5KJoanne M. DonovanCMO↗
  • Aug 12, 26Sell$36KJoanne M. DonovanCMO↗

There are 12 more transactions in this stretch.

Stock compensation, tax and giftsshow the 16 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 1, 26Compensationamount n/aJonathan C Fox↗
  • Aug 12, 26Compensationamount n/aKEVIN KOCHPresident and CEO↗
  • Aug 12, 26Compensationamount n/aKEVIN KOCHPresident and CEO↗
  • Aug 12, 26Compensationamount n/aJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Compensationamount n/aJOHN R MOOREGeneral Counsel↗
  • Aug 12, 26Compensationamount n/aJoanne M. DonovanCMO↗
  • Aug 12, 26Compensationamount n/aJoanne M. DonovanCMO↗
  • Aug 12, 26Compensationamount n/aBehrad DerakhshanChief Business Officer↗
  • Aug 12, 26Compensationamount n/aBehrad DerakhshanChief Business Officer↗
  • Aug 12, 26Compensationamount n/aAlan J RussellChief Scientific Officer↗
  • Aug 12, 26Compensationamount n/aAlan J RussellChief Scientific Officer↗
  • Jul 1, 26Compensationamount n/aJonathan C Fox↗
  • Jul 1, 26Compensation$59KAlan J RussellChief Scientific Officer↗
  • Jul 1, 26Compensation$13KAlan J RussellChief Scientific Officer↗
  • May 5, 26Compensation$354KJoanne M. DonovanCMO↗
  • Apr 1, 26Compensation$203KJoanne M. DonovanCMO↗

The full record holds 171 transactions and goes back to Dec 30, 22.

Its sector and its market

Edgewise Therapeutics, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Edgewise Therapeutics, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Edgewise Therapeutics, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
400 documents on file, from Jan 12, 2021 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Edgewise Therapeutics, Inc. (EWTX): stock price history, insider trades and SEC filings — HornScout